|
Real-time Estimate
Cboe BZX
19:25:36 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 38.94 USD | -1.80% |
|
-8.62% | +28.54% |
| 08-05 | Rapport Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | William Blair Initiates Rapport Therapeutics at Outperform | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.80% | -8.62% | -20.94% | +2.12% | +28.54% | +49.37% | - | - | - | 1.9B | |
| +2.55% | +4.77% | -4.25% | +12.47% | +4.65% | +4.07% | +32.02% | -25.69% | +204.88% | 46.68B | |
| +0.52% | +0.78% | +4.43% | +61.96% | +20.57% | +44.69% | +36.74% | +4.63% | +247.86% | 44.42B | |
| +0.51% | -5.35% | -8.35% | +16.95% | +143.45% | +336.64% | +546.37% | +510.16% | - | 41.32B | |
| -0.68% | +4.91% | -2.28% | +33.74% | +19.65% | +7.61% | +90.74% | -6.35% | +1,065.86% | 41.58B | |
| -1.60% | -0.17% | -7.18% | +4.82% | +3.55% | +9.73% | +43.63% | -21.19% | +131.13% | 30.14B | |
| +0.83% | +1.76% | +1.84% | +38.57% | +12.42% | +26.77% | +160.18% | +231.00% | +2,008.25% | 17.42B | |
| -1.06% | -0.75% | -5.55% | +4.37% | - | - | - | - | - | 15.6B | |
| +1.15% | +7.46% | +7.78% | +24.39% | +26.54% | +25.97% | +43.93% | -36.64% | +91.30% | 15.54B | |
| -0.76% | +12.60% | +17.16% | +62.02% | +31.29% | -9.72% | - | - | - | 14.08B | |
| +3.67% | +5.99% | -3.13% | +59.30% | +44.99% | +87.94% | +44.89% | -35.20% | +248.63% | 13.32B | |
| -0.26% | -1.70% | -2.29% | +20.45% | -6.97% | -0.75% | -32.31% | -38.22% | +121.65% | 13.08B | |
| +0.28% | +0.44% | +0.37% | +30.66% | +23.55% | +36.99% | +4.77% | -45.47% | +165.40% | 11.36B | |
| -1.48% | +4.24% | -7.34% | +95.77% | +56.38% | +26.99% | +61.97% | -54.74% | - | 11.35B | |
| +2.03% | +6.60% | -0.36% | +21.29% | +55.02% | +136.46% | +589.26% | +93.46% | - | 9.78B | |
| +0.31% | +1.85% | -5.60% | +26.98% | +67.23% | +126.41% | +753.65% | +844.15% | +810.03% | 9.38B | |
| -4.69% | -7.94% | -11.93% | +0.70% | -28.24% | +24.50% | +432.68% | +168.74% | +908.17% | 9.06B | |
| -2.12% | +3.41% | +5.15% | +21.09% | -7.20% | -8.74% | -0.16% | -28.12% | +41.05% | 9.26B | |
| +1.71% | -2.60% | -17.19% | +0.45% | +3.40% | +530.58% | +1,310.93% | +1.69% | - | 8.34B | |
| -0.74% | +1.61% | -14.04% | -2.26% | +46.50% | +138.87% | +82.64% | +326.09% | - | 7.68B | |
| Average | -0.10% | +0.60% | -3.68% | +26.79% | +28.70% | +83.92% | +247.17% | +111.08% | +503.68% | 18.57B | |
| Weighted average by Cap. | +0.24% | +1.19% | -2.44% | +28.87% | +33.04% | +77.49% | +186.98% | +97.58% | +490.87% |
- Stock Market
- Stocks
- RAPP Stock
- Sector Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
